Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


Last --
Change Today 0.00 / 0.00%
Volume 0.0
500672 On Other Exchanges
Symbol
Exchange
500672 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

novartis india ltd (500672) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
$-0.41
Shares Outstanding
7.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NOVARTIS INDIA LTD (500672)

Related News

No related news articles were found.

novartis india ltd (500672) Related Businessweek News

No Related Businessweek News Found

novartis india ltd (500672) Details

Novartis India Limited manufactures and sells healthcare products in India and internationally. It operates through four segments: Pharmaceuticals, Generics, Over-The-Counter, and Animal Health. The Pharmaceuticals segment offers a portfolio of prescription medicines through healthcare professionals. The Generics segment offers retail generics products in various therapeutic areas, such as anti-TB, anti-DUB (gynecology), anti-histamines, antibiotics, anti-ulcerants, anti-diabetes, and cardiovascular. The Over-The-Counter segment offers vitamins, minerals, and nutritional supplements, as well as products for the treatment of cough, cold, and allergy. The Animal Health segment offers products for the cattle and poultry markets. The company was founded in 1947 and is based in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.

1,207 Employees
Last Reported Date: 05/27/15
Founded in 1947

novartis india ltd (500672) Top Compensated Officers

Managing Director, Vice Chairman, Chairman of...
Total Annual Compensation: 17.0M
Chief Financial Officer
Total Annual Compensation: 7.5M
Whole Time Director, Member of Corporate Soci...
Total Annual Compensation: 5.3M
Compliance Officer and Company Secretary
Total Annual Compensation: 4.7M
Executive Officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

novartis india ltd (500672) Key Developments

Novartis India Limited Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2015

Novartis India Limited announced unaudited standalone earnings results for the second quarter and six months ended September 30, 2015. For the quarter, the company reported net sales/income from operations (net of excise duty) was INR 2,154.4 million against INR 2,278.3 million a year ago. Profit from operations before other income and finance costs was INR 107.0 million against loss from operations before other income and finance costs of INR 10.5 million a year ago. Profit from ordinary activities before tax was INR 306.9 million against INR 214.1 million a year ago. Net profit was INR 1,038.2 million against INR 140.4 million a year ago. Basic and diluted earnings per share after extraordinary items were INR 32.48 against INR 4.39 a year ago. For the six months, the company reported net sales/income from operations (net of excise duty) was INR 4,314.3 million against INR 4,298.9 million a year ago. Profit from operations before other income and finance costs was INR 110.5 million against loss from operations before other income and finance costs of INR 50.7 million a year ago. Profit from ordinary activities before tax was INR 512.6 million against INR 422.1 million a year ago. Net profit was INR 1,172.7 million against INR 283.5 million a year ago. Basic and diluted earnings per share after extraordinary items were INR 36.69 against INR 8.87 a year ago.

Novartis India Limited, Board Meeting, Nov 05, 2015

Novartis India Limited, Board Meeting, Nov 05, 2015. Agenda: To consider unaudited standalone earnings results for the second quarter and six months ended September 30, 2015.

Novartis India Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015

Novartis India Limited announced unaudited standalone earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported net sales were INR 2,159.69 million against INR 2,020.6 million a year ago. Profit from operations before other income and finance costs was INR 3.5 million against loss from operations before other income and finance costs of INR 40.2 million a year ago. Profit from ordinary activities before tax was INR 205.7 million against INR 208.0 million a year ago. Net profit was INR 134.5 million against INR 143.1 million a year ago. Diluted earnings per share before and after extraordinary items were INR 4.21 against INR 4.48 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HCBA:IN 667.50 INR -3.75

500672 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 500672.
View Industry Companies
 

Industry Analysis

500672

Industry Average

Valuation 500672 Industry Range
Price/Earnings 24.4x
Price/Sales 2.7x
Price/Book 1.8x
Price/Cash Flow 11.9x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NOVARTIS INDIA LTD, please visit www.novartis.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.